Although immunohistological (IHC) staining with Ki67 (Rose et al., 1996) points toward a correlation between the observed tumor reduction and a decreased cellular proliferation rate of animacroxam‐treated tumors, further investigations on bigger sample sizes are warranted to carve out statistical significance. This evidence concerns the gene MKI67 and neoplasm.